Global mRNA Vaccine and Therapeutics Raw Material Market Research Report 2024(Status and Outlook)

Global mRNA Vaccine and Therapeutics Raw Material Market Research Report 2024(Status and Outlook)



Report Overview:

The Global mRNA Vaccine and Therapeutics Raw Material Market Size was estimated at USD 5528.24 million in 2023 and is projected to reach USD 9954.96 million by 2029, exhibiting a CAGR of 10.30% during the forecast period.

This report provides a deep insight into the global mRNA Vaccine and Therapeutics Raw Material market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Vaccine and Therapeutics Raw Material Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Vaccine and Therapeutics Raw Material market in any manner.

Global mRNA Vaccine and Therapeutics Raw Material Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Jena Bioscience

Thermo Fisher Scientific Inc.

SBS Genetech

Sigma Aldrich

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

Etherna

Ethris

Tiba Biotechnology

Product Type Insights

Market Segmentation (by Type)

Infectious Disease Vaccines

Cancer Vaccine

Others

Market Segmentation (by Application)

Hospitals and Clinics

Outpatient and Surgery Centers

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the mRNA Vaccine and Therapeutics Raw Material Market
  • Overview of the regional outlook of the mRNA Vaccine and Therapeutics Raw Material Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Vaccine and Therapeutics Raw Material Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of mRNA Vaccine and Therapeutics Raw Material
1.2 Key Market Segments
1.2.1 mRNA Vaccine and Therapeutics Raw Material Segment by Type
1.2.2 mRNA Vaccine and Therapeutics Raw Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 mRNA Vaccine and Therapeutics Raw Material Market Overview
2.1 Global Market Overview
2.1.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 mRNA Vaccine and Therapeutics Raw Material Market Competitive Landscape
3.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Manufacturers (2019-2024)
3.2 Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Vaccine and Therapeutics Raw Material Sales Sites, Area Served, Product Type
3.6 mRNA Vaccine and Therapeutics Raw Material Market Competitive Situation and Trends
3.6.1 mRNA Vaccine and Therapeutics Raw Material Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Vaccine and Therapeutics Raw Material Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.1 mRNA Vaccine and Therapeutics Raw Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of mRNA Vaccine and Therapeutics Raw Material Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Type (2019-2024)
6.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2019-2024)
7 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Vaccine and Therapeutics Raw Material Market Sales by Application (2019-2024)
7.3 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Vaccine and Therapeutics Raw Material Sales Growth Rate by Application (2019-2024)
8 mRNA Vaccine and Therapeutics Raw Material Market Segmentation by Region
8.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.1 Global mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.1.2 Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Vaccine and Therapeutics Raw Material Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Vaccine and Therapeutics Raw Material Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Jena Bioscience
9.1.1 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Basic Information
9.1.2 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Overview
9.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.1.4 Jena Bioscience Business Overview
9.1.5 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.1.6 Jena Bioscience Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Basic Information
9.2.2 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Overview
9.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 SBS Genetech
9.3.1 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Basic Information
9.3.2 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Overview
9.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.3.4 SBS Genetech mRNA Vaccine and Therapeutics Raw Material SWOT Analysis
9.3.5 SBS Genetech Business Overview
9.3.6 SBS Genetech Recent Developments
9.4 Sigma Aldrich
9.4.1 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Basic Information
9.4.2 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Overview
9.4.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.4.4 Sigma Aldrich Business Overview
9.4.5 Sigma Aldrich Recent Developments
9.5 Moderna Therapeutics
9.5.1 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.5.2 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.5.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.5.4 Moderna Therapeutics Business Overview
9.5.5 Moderna Therapeutics Recent Developments
9.6 CureVac
9.6.1 CureVac mRNA Vaccine and Therapeutics Raw Material Basic Information
9.6.2 CureVac mRNA Vaccine and Therapeutics Raw Material Product Overview
9.6.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.6.4 CureVac Business Overview
9.6.5 CureVac Recent Developments
9.7 Translate Bio
9.7.1 Translate Bio mRNA Vaccine and Therapeutics Raw Material Basic Information
9.7.2 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Overview
9.7.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.7.4 Translate Bio Business Overview
9.7.5 Translate Bio Recent Developments
9.8 BioNTech
9.8.1 BioNTech mRNA Vaccine and Therapeutics Raw Material Basic Information
9.8.2 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Overview
9.8.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.8.4 BioNTech Business Overview
9.8.5 BioNTech Recent Developments
9.9 Sangamo Therapeutics
9.9.1 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.9.2 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.9.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.9.4 Sangamo Therapeutics Business Overview
9.9.5 Sangamo Therapeutics Recent Developments
9.10 Argos Therapeutics
9.10.1 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Basic Information
9.10.2 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Overview
9.10.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.10.4 Argos Therapeutics Business Overview
9.10.5 Argos Therapeutics Recent Developments
9.11 In-Cell-Art
9.11.1 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Basic Information
9.11.2 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Overview
9.11.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.11.4 In-Cell-Art Business Overview
9.11.5 In-Cell-Art Recent Developments
9.12 Etherna
9.12.1 Etherna mRNA Vaccine and Therapeutics Raw Material Basic Information
9.12.2 Etherna mRNA Vaccine and Therapeutics Raw Material Product Overview
9.12.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.12.4 Etherna Business Overview
9.12.5 Etherna Recent Developments
9.13 Ethris
9.13.1 Ethris mRNA Vaccine and Therapeutics Raw Material Basic Information
9.13.2 Ethris mRNA Vaccine and Therapeutics Raw Material Product Overview
9.13.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.13.4 Ethris Business Overview
9.13.5 Ethris Recent Developments
9.14 Tiba Biotechnology
9.14.1 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Basic Information
9.14.2 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Overview
9.14.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.14.4 Tiba Biotechnology Business Overview
9.14.5 Tiba Biotechnology Recent Developments
9.15 Product Type Insights
9.15.1 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Basic Information
9.15.2 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Overview
9.15.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Market Performance
9.15.4 Product Type Insights Business Overview
9.15.5 Product Type Insights Recent Developments
10 mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
10.1 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast
10.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Region
10.2.4 South America mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Vaccine and Therapeutics Raw Material by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of mRNA Vaccine and Therapeutics Raw Material by Type (2025-2030)
11.1.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of mRNA Vaccine and Therapeutics Raw Material by Type (2025-2030)
11.2 Global mRNA Vaccine and Therapeutics Raw Material Market Forecast by Application (2025-2030)
11.2.1 Global mRNA Vaccine and Therapeutics Raw Material Sales (Kilotons) Forecast by Application
11.2.2 Global mRNA Vaccine and Therapeutics Raw Material Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings